These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37150514)

  • 1. Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association.
    Hong AR; Kang HC
    Endocrinol Metab (Seoul); 2023 Apr; 38(2):175-189. PubMed ID: 37150514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of thyroid diseases on bone].
    Tsourdi E; Lademann F; Siggelkow H
    Internist (Berl); 2018 Jul; 59(7):661-667. PubMed ID: 29744522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population.
    Lee K; Lim S; Park H; Woo HY; Chang Y; Sung E; Jung HS; Yun KE; Kim CW; Ryu S; Kwon MJ
    Osteoporos Int; 2020 Mar; 31(3):547-555. PubMed ID: 31720711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid Hormone Diseases and Osteoporosis.
    Delitala AP; Scuteri A; Doria C
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of thyroid hormone on skeletal integrity.
    Greenspan SL; Greenspan FS
    Ann Intern Med; 1999 May; 130(9):750-8. PubMed ID: 10357695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of thyroid diseases on bone metabolism and fracture risk.
    Amashukeli M; Giorgadze E; Tsagareli M; Nozadze N; Jeiranashvili N
    Georgian Med News; 2010; (184-185):34-9. PubMed ID: 20834073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Subclinical Thyroid Dysfunction and Fracture Risk.
    Daya NR; Fretz A; Martin SS; Lutsey PL; Echouffo-Tcheugui JB; Selvin E; Juraschek SP
    JAMA Netw Open; 2022 Nov; 5(11):e2240823. PubMed ID: 36346629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
    Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
    Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between subclinical thyroid dysfunction and depressive symptoms in the Korean adult population: The 2014 Korea National Health and Nutrition Examination Survey.
    Hong JW; Noh JH; Kim DJ
    PLoS One; 2018; 13(8):e0202258. PubMed ID: 30106989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The skeletal consequences of thyrotoxicosis.
    Nicholls JJ; Brassill MJ; Williams GR; Bassett JH
    J Endocrinol; 2012 Jun; 213(3):209-21. PubMed ID: 22454529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
    Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
    Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism.
    Bassett JH; O'Shea PJ; Sriskantharajah S; Rabier B; Boyde A; Howell PG; Weiss RE; Roux JP; Malaval L; Clement-Lacroix P; Samarut J; Chassande O; Williams GR
    Mol Endocrinol; 2007 May; 21(5):1095-107. PubMed ID: 17327419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoporosis in thyroid diseases].
    Kosińska A; Syrenicz A; Kosiński B; Garanty-Bogacka B; Syrenicz M; Gromniak E
    Endokrynol Pol; 2005; 56(2):185-93. PubMed ID: 16335687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
    Heijckmann AC; Huijberts MS; Geusens P; de Vries J; Menheere PP; Wolffenbuttel BH
    Eur J Endocrinol; 2005 Jul; 153(1):23-9. PubMed ID: 15994742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Ménière's disease and thyroid diseases: a nested case-control study.
    Kim SY; Song YS; Wee JH; Min C; Yoo DM; Choi HG
    Sci Rep; 2020 Oct; 10(1):18224. PubMed ID: 33106572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.
    Surks MI; Ortiz E; Daniels GH; Sawin CT; Col NF; Cobin RH; Franklyn JA; Hershman JM; Burman KD; Denke MA; Gorman C; Cooper RS; Weissman NJ
    JAMA; 2004 Jan; 291(2):228-38. PubMed ID: 14722150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling.
    Baliram R; Sun L; Cao J; Li J; Latif R; Huber AK; Yuen T; Blair HC; Zaidi M; Davies TF
    J Clin Invest; 2012 Oct; 122(10):3737-41. PubMed ID: 22996689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
    Biondi B; Cooper DS
    Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on subclinical thyroid dysfunction.
    Hashimoto K
    Endocr J; 2022 Jul; 69(7):725-738. PubMed ID: 35732440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thyroid and osteoporosis].
    Földes J; Lakatos P
    Orv Hetil; 1996 Jun; 137(25):1347-54. PubMed ID: 8757081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.